Article Details

IPR POLICY VS REGULATORY POLICY

Dr. Gopakumar G. Nair

Editor

Indian Drugs

https://doi.org/10.53879/id.59.04.p0005


ABSTRACT

Dear Reader,

Let us get ready to face the global healthcare challenges with positive attributes and approaches to regulatory pathways.

Resisting evergreening and extreme imbalances in Intellectual Property and patient practices may be a good option to continue from the Uruguay Round, TRIPs and the Doha Declaration perspective.

Year 2022 | Volume No. 59 | Issue No.4 | Page No. 5-6
Recent Issue
Current Issue
June 2025
Quick Contact